Search results

AstraZeneca PLC AZN and its Japan-based partner Daiichi Sankyo announced that the FDA has approved their blockbuster antibody-drug conjugate (ADC), Enhertu, for first-line use in breast cancer

In the latest trading session, Norwegian Cruise Line (NCLH) closed at $22.78, marking a +2.06% move from the previous day. This move outpaced the S&P 500's daily gain of 0.19%. At the same time, the

Incyte INCY announced positive top-line results from a late-stage lymphoma study of Monjuvi/Minjuvi (tafasitamab), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, in the

Helen of Troy Limited (HELE) reported mixed third-quarter fiscal 2026 results, with the top line beating the Zacks Consensus Estimate and the bottom line matching the same. Both net sales and

Target Corporation’s TGT ongoing shrink normalization is shaping up as one of the most visible contributors to near-term margin stabilization, even as top-line trends remain pressured. After

Veracyte VCYT is making solid progress in its Afirma business line. The company’s Decipher franchise continues to be a strong tailwind, with remarkable test volume growth. Sound financial health

For Immediate Release

Chicago, IL – December 24, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Norwegian Cruise Line Holdings Ltd. NCLH continues to see momentum in pre-cruise and onboard revenue execution, with management highlighting record pre-cruise sales and higher attachment rates

Sandisk SNDK is riding on strong datacenter revenue growth, which increased 26% sequentially in the first quarter of fiscal 2026, driven by strong demand for the “Stargate” product line. Growing

Meta Platforms META is infusing AI to improve content recommendations and ad ranking. This is helping the company keep users across its platform engaged. AI recommendations that deliver higher

Net profit, also referred to as the bottom line, is one of the key tools to determine the financial health of an enterprise. The metric demonstrates a company’s ability to convert per-dollar sales

Coty Inc.’s (COTY) first-quarter fiscal 2026 performance highlights the growing strategic relevance of e-commerce, even as it navigates broader top-line pressure from trade destocking. In the fiscal

Westinghouse Air Brake Technologies WAB, operating as Wabtec, has seen its top line bolstered by robust backlog growth. This, in turn, has boosted the company’s overall performance

Medifast, Inc. MED is strategically transitioning beyond its traditional identity as a weight-loss company toward becoming a broader leader in metabolic health. As part of this evolution, the

Prudential Financial Inc. PRU shares are trading at a discount compared to the Zacks Multi-line Insurance industry. Its shares are currently trading at a price-to-earnings multiple of 7.62, which is

Norwegian Cruise Line Holdings Ltd. NCLH is positioning 2026 as a pivotal year in its multi-year recovery, with management signaling that operational improvements are beginning to translate into

AbbVie ABBV has built a substantial neuroscience franchise. While the segment was initially anchored by Botox Therapeutic and the depression drug Vraylar, its offerings now include the oral migraine

Carnival Corporation & plc CCL and Norwegian Cruise Line Holdings Ltd. NCLH are both entering 2026 with strong demand trends, improving execution and destination-driven strategies that are reshaping